. . . . . . . "[Herein, we evaluated the anti-tumor activity of a commercially available PR modulator, ulipristal acetate (UPA), and a new selective and passive PR antagonist 'APR19' in a novel preclinical approach based on patient-derived breast tumor (HBCx-34) xenografted in nude mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:15:17+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .